KovaDx
New Haven
About KovaDx
Millions of people suffer from Sickle Cell Disease and other hemolytic anemias. KovaDx is making healthcare accessible to these individuals by providing an affordable and easy to use point-of-care solution. Our system is based on Quantitative Phase Imaging and uses deep learning to make predictions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $356.0K
- Funding stage: Seed
- Last round: Grant (Aug 2021)
- Website: kovadx.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/kovadx-93710 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.